SEI Investments’s Outset Medical OM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$136K Buy
35,366
+4,738
+15% +$19.4K ﹤0.01% 3041
2025
Q4
$114K Buy
+30,628
New +$263K ﹤0.01% 2997
2024
Q2
Sell
-1,818
Closed -$60.5K 2710
2024
Q1
$60.5K Buy
+1,818
New +$92.1K ﹤0.01% 2550
2023
Q3
Sell
-6,311
Closed -$2.07M 2670
2023
Q2
$2.07M Buy
6,311
+364
+6% +$111K ﹤0.01% 1622
2023
Q1
$1.64M Buy
+5,947
New +$2.18M ﹤0.01% 1707
2022
Q4
Sell
-5,339
Closed -$1.28M 2636
2022
Q3
$1.28M Sell
5,339
-1,841
-26% -$493K ﹤0.01% 1715
2022
Q2
$1.6M Buy
7,180
+4,647
+183% +$2M ﹤0.01% 1656
2022
Q1
$1.73M Buy
2,533
+66
+3% +$39.7K ﹤0.01% 1596
2021
Q4
$1.71M Sell
2,467
-66
-3% -$48.8K ﹤0.01% 1649
2021
Q3
$1.88M Sell
2,533
-400
-14% -$273K ﹤0.01% 1539
2021
Q2
$2.2M Buy
2,933
+133
+5% +$102K ﹤0.01% 1473
2021
Q1
$2.28M Buy
2,800
+960
+52% +$741K 0.01% 1391
2020
Q4
$1.57M Buy
+1,840
New +$1.42M ﹤0.01% 1495

Other funds holding OM

SEI Investments's OM Position: Q1 2026 in Review

SEI Investments increased its Outset Medical (OM) stake by 15% in Q1 2026, buying an estimated $19.4K and bringing the position to 35,366 shares worth $136K. The position accounts for ﹤0.01% of the portfolio, ranked #3041.

SEI Investments first reported a position in OM in Q4 2020 and has held it in 13 quarters since. The position peaked at $2.28M in Q1 2021. 99 funds tracked by Wall St. Rank hold OM as of Q1 2026.

  • SEI Investments held 35,366 shares of Outset Medical worth $136K as of Q1 2026.
  • SEI Investments bought 4,738 Outset Medical shares in Q1 2026, an estimated $19.4K.
  • Outset Medical made up ﹤0.01% of SEI Investments's portfolio in Q1 2026, its #3041 holding.
  • SEI Investments first reported a position in Outset Medical in Q4 2020 and has held it in 13 quarters since.
  • SEI Investments's Outset Medical position peaked at $2.28M in Q1 2021.
  • 99 funds tracked by Wall St. Rank held Outset Medical as of Q1 2026.

Based on SEI Investments's 13F filing for Q1 2026, filed 13 May 2026.